[{"address1": "8181 Arista Place", "address2": "Suite 100", "city": "Broomfield", "state": "CO", "zip": "80021", "country": "United States", "phone": "833 275 2266", "website": "https://www.aclarion.com", "industry": "Health Information Services", "industryKey": "health-information-services", "industryDisp": "Health Information Services", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in Broomfield, Colorado.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeffrey John Thramann M.D.", "age": 58, "title": "Executive Chairman", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 300000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.14, "open": 2.1, "dayLow": 1.83, "dayHigh": 2.2, "regularMarketPreviousClose": 2.14, "regularMarketOpen": 2.1, "regularMarketDayLow": 1.83, "regularMarketDayHigh": 2.2, "forwardPE": -6.4310346, "volume": 79209, "regularMarketVolume": 79209, "averageVolume": 666472, "averageVolume10days": 239310, "averageDailyVolume10Day": 239310, "bidSize": 1200, "askSize": 800, "marketCap": 2391042, "fiftyTwoWeekLow": 1.83, "fiftyTwoWeekHigh": 37.92, "priceToSalesTrailing12Months": 28.421814, "fiftyDayAverage": 3.87668, "twoHundredDayAverage": 8.55413, "currency": "USD", "enterpriseValue": 1591021, "floatShares": 441414, "sharesOutstanding": 840000, "sharesShort": 212060, "sharesShortPriorMonth": 77, "sharesShortPreviousMonthDate": 1702598400, "dateShortInterest": 1705017600, "sharesPercentSharesOut": 0.2525, "heldPercentInsiders": 0.1972, "heldPercentInstitutions": 0.14066, "shortRatio": 0.12, "shortPercentOfFloat": 0.2841, "impliedSharesOutstanding": 1282060, "bookValue": -1.61, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -4590637, "trailingEps": -9.28, "forwardEps": -0.29, "lastSplitFactor": "1:16", "lastSplitDate": 1704326400, "enterpriseToRevenue": 18.912, "enterpriseToEbitda": -0.351, "52WeekChange": -0.80755395, "SandP52WeekChange": 0.20233083, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ACON", "underlyingSymbol": "ACON", "shortName": "Aclarion, Inc.", "longName": "Aclarion, Inc.", "firstTradeDateEpochUtc": 1650634200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "e788cafd-f3cb-3638-aec4-1ba7a1daacb1", "messageBoardId": "finmb_108179695", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.865, "targetHighPrice": 48.0, "targetLowPrice": 48.0, "targetMeanPrice": 48.0, "targetMedianPrice": 48.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 161450, "totalCashPerShare": 0.294, "ebitda": -4531943, "totalDebt": 727536, "quickRatio": 0.077, "currentRatio": 0.154, "totalRevenue": 84127, "revenuePerShare": 0.165, "returnOnAssets": -1.0391101, "returnOnEquity": -4.36216, "freeCashflow": -1795819, "operatingCashflow": -4048218, "revenueGrowth": 0.046, "grossMargins": 0.12512, "operatingMargins": -60.95856, "financialCurrency": "USD", "trailingPegRatio": null}]